New Delhi: The Pune-based Serum Institute of India (SII) will start manufacturing the anti-COVID vaccine Sputnik V from September, Russian…
Pune: India's premier vaccine manufacturer, Serum Institute of India (SII), has sought permission from Drugs Controller General of India (DCGI)…
Pune: Serum Institute of India (SII) confirmed that it suffered losses to the tune of Rs 1,000 crore in Thursday’s…
Pune: The fire at Serum Institute of India (SII) that killed five workers on Thursday won’t result in any loss…
Pune: Five persons lost their lives after a fire broke out at an under-construction site in Serum Institute of India’s…
Pune: The CEO of Serum Institute of India (SII), Adar Poonawalla, on Tuesday said his firm has decided to sell…
New Delhi: A day ahead of the scheduled dry run for vaccination in all the states, a government-appointed panel of…
New Delhi: India will require funding of Rs 80,000 crore for distribution of the COVID vaccine for the next one…
New Delhi: Serum Institute of India (SII) and Bharat Biotech have not been granted emergency use authorisation of their coronavirus…
New Delhi: The Serum Institute of India (SII) has sought emergency use authorisation of its vaccine candidate Covishield in the…